TOM1L2
Basic information
Region (hg38): 17:17843507-17972422
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TOM1L2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 27 | 28 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 27 | 1 | 0 |
Variants in TOM1L2
This is a list of pathogenic ClinVar variants found in the TOM1L2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-17847639-A-C | not specified | Uncertain significance (Jun 10, 2024) | ||
17-17847640-G-C | not specified | Uncertain significance (Sep 22, 2022) | ||
17-17847678-C-T | not specified | Uncertain significance (Mar 21, 2023) | ||
17-17847717-G-A | not specified | Uncertain significance (Aug 12, 2022) | ||
17-17847733-C-T | not specified | Likely benign (Feb 28, 2023) | ||
17-17848828-C-T | not specified | Uncertain significance (Sep 14, 2022) | ||
17-17848831-G-T | not specified | Uncertain significance (Jan 12, 2024) | ||
17-17848835-C-T | not specified | Uncertain significance (Dec 15, 2023) | ||
17-17848856-C-A | not specified | Uncertain significance (May 18, 2023) | ||
17-17861489-T-C | not specified | Uncertain significance (May 11, 2022) | ||
17-17861499-T-C | not specified | Uncertain significance (Nov 17, 2022) | ||
17-17866341-T-C | not specified | Uncertain significance (Oct 05, 2021) | ||
17-17866365-C-A | not specified | Uncertain significance (May 04, 2022) | ||
17-17869344-C-G | not specified | Uncertain significance (Sep 27, 2022) | ||
17-17869359-C-T | not specified | Uncertain significance (May 10, 2022) | ||
17-17869395-C-T | not specified | Uncertain significance (Feb 22, 2024) | ||
17-17869409-T-C | not specified | Uncertain significance (May 30, 2023) | ||
17-17879657-C-G | not specified | Uncertain significance (Nov 07, 2023) | ||
17-17879716-C-T | not specified | Uncertain significance (Jul 20, 2021) | ||
17-17882781-G-A | not specified | Uncertain significance (Aug 02, 2022) | ||
17-17882782-G-C | not specified | Uncertain significance (Feb 14, 2023) | ||
17-17882784-G-A | not specified | Uncertain significance (Mar 07, 2024) | ||
17-17882823-G-A | not specified | Uncertain significance (Dec 11, 2023) | ||
17-17884672-C-A | not specified | Uncertain significance (Jan 19, 2024) | ||
17-17884678-T-C | not specified | Uncertain significance (Nov 09, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TOM1L2 | protein_coding | protein_coding | ENST00000379504 | 15 | 128909 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00157 | 0.998 | 125731 | 0 | 17 | 125748 | 0.0000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.678 | 280 | 314 | 0.892 | 0.0000187 | 3293 |
Missense in Polyphen | 76 | 89.62 | 0.84802 | 971 | ||
Synonymous | -0.730 | 137 | 127 | 1.08 | 0.00000825 | 1024 |
Loss of Function | 3.53 | 11 | 32.8 | 0.335 | 0.00000208 | 313 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000211 | 0.000211 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000706 | 0.0000703 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Probable role in protein transport. May regulate growth factor-induced mitogenic signaling. {ECO:0000269|PubMed:16412388, ECO:0000269|PubMed:16479011}.;
- Pathway
- Fibroblast growth factor-1;EGFR1
(Consensus)
Recessive Scores
- pRec
- 0.116
Intolerance Scores
- loftool
- 0.547
- rvis_EVS
- -1.16
- rvis_percentile_EVS
- 6.17
Haploinsufficiency Scores
- pHI
- 0.198
- hipred
- Y
- hipred_score
- 0.605
- ghis
- 0.650
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.921
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tom1l2
- Phenotype
- vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); neoplasm; reproductive system phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); growth/size/body region phenotype; craniofacial phenotype; endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan);
Gene ontology
- Biological process
- intracellular protein transport;signal transduction;negative regulation of mitotic nuclear division
- Cellular component
- cell;extracellular exosome
- Molecular function
- protein binding;protein kinase binding;clathrin binding